Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AF465 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Goat Polyclonal PlGF-2 Antibody
- Antibody type
- Polyclonal
Submitted references Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction.
Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema.
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
Iwama H, Uemura S, Naya N, Imagawa K, Takemoto Y, Asai O, Onoue K, Okayama S, Somekawa S, Kida Y, Takeda Y, Nakatani K, Takaoka M, Kawata H, Horii M, Nakajima T, Doi N, Saito Y
Journal of the American College of Cardiology 2006 Apr 18;47(8):1559-67
Journal of the American College of Cardiology 2006 Apr 18;47(8):1559-67
Overexpression of placenta growth factor contributes to the pathogenesis of pulmonary emphysema.
Tsao PN, Su YN, Li H, Huang PH, Chien CT, Lai YL, Lee CN, Chen CA, Cheng WF, Wei SC, Yu CJ, Hsieh FJ, Hsu SM
American journal of respiratory and critical care medicine 2004 Feb 15;169(4):505-11
American journal of respiratory and critical care medicine 2004 Feb 15;169(4):505-11
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA
The Journal of clinical investigation 2003 Mar;111(5):649-58
The Journal of clinical investigation 2003 Mar;111(5):649-58
No comments: Submit comment
No validations: Submit validation data